Related Experiment Videos
Bladder transplantation in rats using FK-506.
A Yamataka1, K Wang, H Kobayashi
1Department of Pediatric Surgery, Juntendo University School of Medicine, Tokyo, Japan.
The Journal of Urology
|July 4, 2001
Summary
FK-506 immunosuppression enabled successful bladder tissue transplantation and survival in rats. This technique shows potential for bladder augmentation in patients with conditions like bladder exstrophy.
Area of Science:
- Regenerative Medicine
- Transplantation Immunology
- Urology
Background:
- Bladder reconstruction is crucial for treating congenital anomalies and acquired conditions.
- Graft rejection remains a significant challenge in bladder transplantation.
Purpose of the Study:
- To assess the efficacy of FK-506 immunosuppression in preventing rejection of transplanted bladder tissue.
- To evaluate the viability and functionality of bladder grafts for potential augmentation procedures.
Main Methods:
- Rat bladder grafts were transplanted into recipient rats, with one group receiving FK-506 and a control group receiving no immunosuppression.
- Graft survival, rejection, and nerve integrity were assessed via histological and immunohistochemical analyses.
- Bladder augmentation was performed in a subset of rats to evaluate functional outcomes.
Main Results:
- Overall bladder graft survival was 96.4%.
- FK-506 significantly reduced or eliminated graft rejection compared to controls.
- Transplanted bladders in the FK-506 group maintained intact nerve distribution and normal mucosal histology.
Conclusions:
- FK-506 effectively prevents rejection in bladder transplantation, creating viable tissue.
- This immunosuppression-based technique holds promise for bladder augmentation in conditions like vesical exstrophy and neurogenic bladder.